Buy & Sell BioNTech SE - ADR (BNTX) – BioNTech SE - ADR Price Today
Key Stats
- $22.65BMarket Cap
- HealthSector
- -24.35%3M Drawdown
- $5.85BEnterprise Value
- -Dividend Yield
- 53 daysTypical Hold Time
BioNTech SE - ADR (BNTX) is currently valued at a market capitalization of $22.65B, with an enterprise value of $5.85B. Over the past 52 weeks, BioNTech SE - ADR has traded between a low of $83.89 and a high of $119.34, highlighting its annual price range. Over the past three months, BioNTech SE - ADR has recorded a drawdown of -24.35%, reflecting recent price volatility. On average, investors hold BioNTech SE - ADR for approximately 53 days, indicating typical investor behavior on the platform.
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Most Recent News
Travelzoo launches exclusive UK luxury travel deals with up to 47% off for members
Travelzoo has announced new exclusive travel deals for its UK Club Members, offering significant discounts on luxury hotel stays and city breaks. Highlights include a 47% discount on a 5-star London hotel with champagne breakfast, a chic Rome city br...
Quality data, not big data, drives efficiency and AI success in process industries.
At the OPTIMIZE 26 conference, industry experts emphasized that quality data—defined by business relevance—is crucial for effective AI and process optimization in industries like refining and fertilizers. Unlike big data, which focuses on volume, qua...
Rising U.S. Treasury yields block Bitcoin's breakout above $82,000 despite positive crypto news.
Bitcoin's recent attempts to break above $82,000 have been hindered by rising U.S. Treasury yields, with the 2-year yield hitting 4.09% and the 10-year surpassing 4.5%. Higher yields make low-risk government bonds more attractive, reducing appetite f...
